{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:48:52Z","timestamp":1789220932250,"version":"build-2803163510"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Leishmaniasis is a parasitic disease caused by\n                      <jats:italic>Leishmania<\/jats:italic>\n                      species and transmitted through sand fly bites, affecting some of the most vulnerable populations globally. Current treatments are limited by high toxicity, poor tolerability, and resistance. Plant-based therapies offer a promising alternative, but human evidence has not been comprehensively reviewed. This review summarizes current evidence on the efficacy and safety of plant-based treatments for leishmaniasis in humans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology\/findings<\/jats:title>\n                    <jats:p>\n                      We conducted a systematic review including studies that evaluated the efficacy and safety of plant-based treatments for leishmaniasis in humans. This review was registered with PROSPERO (ID: CRD42024567764). We searched PubMed, Scopus, and Web of Science from inception to May 28, 2024. Risk of bias was assessed using the Cochrane RoB 2 tool. We summarized the main study results qualitatively and quantitatively (where possible) by estimating risk ratios with 95% confidence intervals for treatment outcomes using the\n                      <jats:italic>meta<\/jats:italic>\n                      package in R. Ten studies met the inclusion criteria, nine from Iran and one from Sudan, all focused on cutaneous leishmaniasis (CL). Most used topical creams derived from medicinal plants, either alone or with conventional treatments. In studies combining herbal and standard treatments, four of six studies showed better outcomes in the intervention group. In studies using only the plant-based treatments compared to a standard treatment group, two of four showed better outcomes in the intervention group. Quantitative analysis of eight studies indicated significant healing improvements in the intervention group in three studies, specifically those using\n                      <jats:italic>Juniperus excelsa, Nigella sativa<\/jats:italic>\n                      , and poly-herbal formulations consisting of the pure extract mixture of\n                      <jats:italic>Althaea (A.) rosa<\/jats:italic>\n                      ,\n                      <jats:italic>A. officinalis<\/jats:italic>\n                      , and members of the families Leguminosae, Faliaceae, Malvaceae, and Lythraceae (named Z-HE). Mild side effects such as itching and burning were reported with some herbal treatments, while conventional therapies caused more severe reactions in some cases. The risk of bias was mostly high in the studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This review highlights the potential of certain plant-based compounds as adjunct or alternative therapies for CL. Despite promising results with\n                      <jats:italic>Plantago ovata, Juniperus excelsa<\/jats:italic>\n                      , and Z-HE poly-herbal extracts, current evidence is limited by methodological weaknesses. Larger, rigorously designed trials with broader representation are needed to confirm efficacy and safety and support policy integration in endemic regions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0014389","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:33:01Z","timestamp":1780680781000},"page":"e0014389","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plant-based therapeutics for leishmaniasis: A systematic review emphasizing human studies and clinical trial evidence"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3027-6353","authenticated-orcid":true,"given":"Alberta Serwah","family":"Anning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Osmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie J.","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Obiri-Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"pntd.0014389.ref001","unstructured":"Centers for Disease Control and Prevention (CDC). Leishmaniasis Atlanta: Centres for Disease Control and Prevention; 2024. https:\/\/www.cdc.gov\/leishmaniasis\/about\/index.html"},{"issue":"3","key":"pntd.0014389.ref002","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human leishmaniasis","volume":"94","author":"I Okwor","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"pntd.0014389.ref003","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jep.2011.07.022","article-title":"In vitro antitrypanosomal and antileishmanial activity of plants used in Benin in traditional medicine and bio-guided fractionation of the most active extract","volume":"137","author":"J Bero","year":"2011","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"pntd.0014389.ref004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijwd.2019.01.002","article-title":"Cutaneous leishmaniasis: a neglected disfiguring disease for women","volume":"5","author":"A Bilgic-Temel","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"pntd.0014389.ref005","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"S Sundar","year":"2016","journal-title":"Ther Adv Infect Dis"},{"issue":"11","key":"pntd.0014389.ref006","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/su8111131","article-title":"Bioactivity of phycocolloids against the mediterranean protozoan leishmania infantum: an inceptive study","volume":"8","author":"S Armeli Minicante","year":"2016","journal-title":"Sustainability"},{"key":"pntd.0014389.ref007","unstructured":"World Health Organization (WHO). Leishmaniasis (fact sheet). 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis"},{"issue":"5","key":"pntd.0014389.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"10151","key":"pntd.0014389.ref009","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"S Burza","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"pntd.0014389.ref010","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/microorganisms10101887","article-title":"Visceral leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics","volume":"10","author":"S Scarpini","year":"2022","journal-title":"Microorganisms"},{"issue":"12","key":"pntd.0014389.ref011","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw742","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"N Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pntd.0014389.ref012","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0020-7519(03)00142-5","article-title":"Two separate growth phases during the development of Leishmania in sand flies: implications for understanding the life cycle","volume":"33","author":"SM Gossage","year":"2003","journal-title":"Int J Parasitol"},{"issue":"11","key":"pntd.0014389.ref013","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"SL Croft","year":"2005","journal-title":"Trends Parasitol"},{"issue":"1","key":"pntd.0014389.ref014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"pntd.0014389.ref015","article-title":"The global procurement landscape of leishmaniasis medicines","volume":"15","author":"HL Choi","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014389.ref016","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0454-2020","article-title":"Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil","volume":"54","author":"JP Carvalho","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"pntd.0014389.ref017","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1590\/0037-8682-0133-2017","article-title":"The direct costs of treating human visceral leishmaniasis in Brazil","volume":"50","author":"TSM Assis","year":"2017","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"1","key":"pntd.0014389.ref018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bmc.2013.11.048","article-title":"Natural product based leads to fight against leishmaniasis","volume":"22","author":"N Singh","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"pntd.0014389.ref019","first-page":"1","article-title":"Plant-derived compounds in treatment of leishmaniasis","volume":"16","author":"A Oryan","year":"2015","journal-title":"Iran J Vet Res"},{"issue":"9","key":"pntd.0014389.ref020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.apjtb.2015.05.018","article-title":"Leishmaniosis phytotherapy: Review of plants used in Iranian traditional medicine on leishmaniasis","volume":"5","author":"M Bahmani","year":"2015","journal-title":"Asian Pacific Journal of Tropical Biomedicine"},{"issue":"12","key":"pntd.0014389.ref021","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/ptr.5710","article-title":"Plants as antileishmanial agents: current scenario","volume":"30","author":"N Ullah","year":"2016","journal-title":"Phytother Res"},{"issue":"7","key":"pntd.0014389.ref022","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.000050","article-title":"In vitro activity of Erythrophleum ivorense extract against the promastigote stage of cutaneous Leishmania parasite, a member of Leishmania (Mundinia) enriettii complex isolates from Ghana","volume":"1","author":"AS Anning","year":"2019","journal-title":"Access Microbiol"},{"issue":"22","key":"pntd.0014389.ref023","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038480","article-title":"Medicinal plants with promising antileishmanial activity in Ethiopia: a systematic review and meta-analysis","volume":"103","author":"KM Worku","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"21","key":"pntd.0014389.ref024","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.3390\/molecules27217579","article-title":"Antileishmanial activities of medicinal herbs and phytochemicals in vitro and in vivo: an update for the years 2015 to 2021","volume":"27","author":"AA Hassan","year":"2022","journal-title":"Molecules"},{"issue":"13","key":"pntd.0014389.ref025","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1017\/S0031182020001304","article-title":"Effect of essential oils on Leishmania amazonensis: a systematic review","volume":"147","author":"CE de Lara da Silva","year":"2020","journal-title":"Parasitology"},{"issue":"1","key":"pntd.0014389.ref026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2156587215623126","article-title":"Antileishmanial and immunomodulatory activity of Allium sativum (garlic): a review","volume":"22","author":"M Foroutan-Rad","year":"2017","journal-title":"Journal of Evidence-Based Complementary & Alternative Medicine"},{"key":"pntd.0014389.ref027","doi-asserted-by":"crossref","first-page":"655584","DOI":"10.3389\/fmolb.2021.655584","article-title":"Green approach: \u201c\u2018A forwarding step for curing leishmaniasis-a neglected tropical disease\u2019\u201d","volume":"8","author":"L Sharma","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"1","key":"pntd.0014389.ref028","article-title":"An update on natural antileishmanial treatment options from plants, fungi and algae","volume":"19","author":"WS Koko","year":"2022","journal-title":"Chemistry & Biodiversity"},{"key":"pntd.0014389.ref029","doi-asserted-by":"crossref","first-page":"108554","DOI":"10.1016\/j.exppara.2023.108554","article-title":"Promising natural products for the treatment of cutaneous leishmaniasis: a review of in vitro and in vivo studies","volume":"251","author":"RC Afonso","year":"2023","journal-title":"Exp Parasitol"},{"issue":"4","key":"pntd.0014389.ref030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/20477724.2020.1754655","article-title":"Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies","volume":"114","author":"S Cortes","year":"2020","journal-title":"Pathog Glob Health"},{"key":"pntd.0014389.ref031","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"key":"pntd.0014389.ref032","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"pntd.0014389.ref033","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/2211362611208020111","article-title":"Laboratory studies and clinical trials on new formulations from garlic extract against cutaneous leishmaniasis","volume":"10","author":"A Samdani","year":"2012","journal-title":"AIA"},{"issue":"2","key":"pntd.0014389.ref034","first-page":"145","article-title":"Erysipeloid cutaneous leishmaniasis: treatment with a new, topical, pure herbal extract","volume":"13","author":"F Zerehsaz","year":"2003","journal-title":"Eur J Dermatol"},{"key":"pntd.0014389.ref035","article-title":"Efficacy of adding topical honey-based hydroalcoholic extract nigella sativa 60% compared to honey alone in patients with cutaneous leishmaniasis receiving intralesional glucantime","volume":"1","author":"MA Nilforoushzadeh","year":"2010","journal-title":"Journal of Skin & Leishmaniasis"},{"issue":"8","key":"pntd.0014389.ref036","first-page":"129","article-title":"Treatment of cutaneous leishmaniasis with some local Sudanese plants (Neem, Garad & Garlic)","volume":"23","author":"FA Khalid","year":"2004","journal-title":"T\u00fcrkiye Parazitoloji Dergisi"},{"issue":"3","key":"pntd.0014389.ref037","first-page":"2","article-title":"Treatment of cutaneous leishmaniasis with 5% garlic cream: a randomized, double-blind study","volume":"3","author":"AR Gholami","year":"2000","journal-title":"Iranian Journal of Dermatology"},{"issue":"3","key":"pntd.0014389.ref038","doi-asserted-by":"crossref","first-page":"334","DOI":"10.62940\/als.v9i3.1497","article-title":"Investigating potential therapeutic efficacy of 5% topical ointment of Sambucus ebulus fruit extract in treatment of cutaneous leishmaniasis","volume":"9","author":"MA Ebrahimzadeh","year":"2022","journal-title":"Advancements in Life Sciences"},{"issue":"1","key":"pntd.0014389.ref039","first-page":"25","article-title":"The therapeutic effect of ozonated olive oil plus glucantime on human cutaneous leishmaniasis","volume":"22","author":"M Aghaei","year":"2019","journal-title":"Iran J Basic Med Sci"},{"issue":"8","key":"pntd.0014389.ref040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-4362.1999.00727.x","article-title":"A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran","volume":"38","author":"F Zerehsaz","year":"1999","journal-title":"Int J Dermatol"},{"key":"pntd.0014389.ref041","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/abr.abr_376_21","article-title":"Examination of the topical effect of the combination of plantago ovata and vinegar on the improvement of rural cutaneous leishmaniasis lesions","volume":"12","author":"M Ebrahimzadeh Ardakani","year":"2023","journal-title":"Adv Biomed Res"},{"issue":"10","key":"pntd.0014389.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005957","article-title":"Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial","volume":"11","author":"MM Parvizi","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0014389.ref043","doi-asserted-by":"crossref","DOI":"10.17795\/jssc16631","article-title":"Concentrated extracts of cassia fistula versus intralesional injection of meglumine antimoniate in treatment of acute cutaneous leishmaniasis","volume":"1","author":"F Jaffary","year":"2014","journal-title":"J Skin Stem Cell"},{"key":"pntd.0014389.ref044","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2277-9175.129717","article-title":"The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major","volume":"3","author":"F Jaffary","year":"2014","journal-title":"Adv Biomed Res"},{"issue":"3","key":"pntd.0014389.ref045","first-page":"739","article-title":"Plantago ovata: a comprehensive review on cultivation, biochemical, pharmaceutical and pharmacological aspects","volume":"74","author":"RM Sarfraz","year":"2017","journal-title":"Acta Pol Pharm"},{"issue":"4","key":"pntd.0014389.ref046","first-page":"1443","article-title":"A comparative evaluation of Juniperus species with antimicrobial magistrals","volume":"33","author":"H Muftah","year":"2020","journal-title":"Pak J Pharm Sci"},{"issue":"2","key":"pntd.0014389.ref047","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11418-011-0605-z","article-title":"Pharmacological explanation for the medicinal use of Juniperus excelsa in hyperactive gastrointestinal and respiratory disorders","volume":"66","author":"M Khan","year":"2012","journal-title":"J Nat Med"},{"issue":"3","key":"pntd.0014389.ref048","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10641963.2011.631651","article-title":"Cardiovascular effects of Juniperus excelsa are mediated through multiple pathways","volume":"34","author":"M Khan","year":"2012","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"pntd.0014389.ref049","first-page":"458","article-title":"Plant bioactive ingredients in delivery systems and nanocarriers for the treatment of leishmaniasis: an evidence-based review","volume":"17","author":"AD Alanazi","year":"2022","journal-title":"Iran J Parasitol"},{"issue":"4","key":"pntd.0014389.ref050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"A Asilian","year":"2004","journal-title":"Int J Dermatol"},{"issue":"4","key":"pntd.0014389.ref051","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1645\/GE-185R","article-title":"Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey","volume":"90","author":"S Uzun","year":"2004","journal-title":"J Parasitol"},{"issue":"2","key":"pntd.0014389.ref052","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.2009.80.172","article-title":"Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children","volume":"80","author":"P Layegh","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0014389.ref053","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5582\/ddt.2020.03056","article-title":"Althaea officinalis improves wound healing in rats: a stereological study","volume":"14","author":"M Mohsenikia","year":"2020","journal-title":"Drug Discov Ther"},{"issue":"4","key":"pntd.0014389.ref054","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5114\/pdia.2014.40934","article-title":"Clinical and sebumetric evaluation of topical emulsions in the treatment of acne vulgaris","volume":"31","author":"BA Khan","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"pntd.0014389.ref055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14767058.2016.1275549","article-title":"The effect of Achillea millefolium and Hypericum perforatum ointments on episiotomy wound healing in primiparous women","volume":"31","author":"M Hajhashemi","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"pntd.0014389.ref056","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jep.2017.02.002","article-title":"The estimation of the traditionally used yarrow (Achillea millefolium L. Asteraceae) oil extracts with anti-inflamatory potential in topical application","volume":"199","author":"V Tadi\u0107","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"pntd.0014389.ref057","doi-asserted-by":"crossref","first-page":"105235","DOI":"10.1016\/j.micpath.2021.105235","article-title":"The effects of medicinal herbs and marine natural products on wound healing of cutaneous leishmaniasis: a systematic review","volume":"161","author":"E Tajbakhsh","year":"2021","journal-title":"Microb Pathog"},{"key":"pntd.0014389.ref058","doi-asserted-by":"crossref","first-page":"106117","DOI":"10.1016\/j.phrs.2022.106117","article-title":"Effects of terpenes in the treatment of visceral leishmaniasis: a systematic review of preclinical evidence","volume":"177","author":"VD Raimundo","year":"2022","journal-title":"Pharmacological Research"},{"issue":"3","key":"pntd.0014389.ref059","first-page":"91","article-title":"Systemic treatments of leishmaniasis: a narrative review","volume":"6","author":"AR Taheri","year":"2019","journal-title":"Reviews in Clinical Medicine"},{"issue":"2","key":"pntd.0014389.ref060","first-page":"563","article-title":"Plantago ovata: clinical study of overuse","volume":"29","author":"R-N Agha","year":"2016","journal-title":"Pak J Pharm Sci"},{"issue":"11","key":"pntd.0014389.ref061","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1517\/17425255.2012.716038","article-title":"Drug interactions with the dietary fiber Plantago ovata husk","volume":"8","author":"N Fernandez","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"pntd.0014389.ref062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"A Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014389.ref063","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jep.2017.01.048","article-title":"Treating leishmaniasis in Amazonia: a review of ethnomedicinal concepts and pharmaco-chemicgal analysis of traditional treatments to inspire modern phytotherapies","volume":"199","author":"G Odonne","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"pntd.0014389.ref064","doi-asserted-by":"crossref","first-page":"1642005","DOI":"10.3389\/fphar.2025.1642005","article-title":"Flavonoids in the treatment of Leishmania amazonensis: a review of efficacy and mechanisms","volume":"16","author":"VL Lessa","year":"2025","journal-title":"Front Pharmacol"},{"key":"pntd.0014389.ref065","doi-asserted-by":"crossref","first-page":"1260448","DOI":"10.3389\/fcimb.2023.1260448","article-title":"Exploring the leishmanicidal potential of terpenoids: a comprehensive review on mechanisms of cell death","volume":"13","author":"ACJ Rodrigues","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pntd.0014389.ref066","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/microorganisms11010225","article-title":"Flavonoid derivatives as new potent inhibitors of cysteine proteases: an important step toward the design of new compounds for the treatment of leishmaniasis","volume":"11","author":"EMG Louren\u00e7o","year":"2023","journal-title":"Microorganisms"},{"issue":"4","key":"pntd.0014389.ref067","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11101-016-9455-3","article-title":"Natural products from marine invertebrates against Leishmania parasites: a comprehensive review","volume":"15","author":"M Oliveira","year":"2016","journal-title":"Phytochem Rev"},{"issue":"11","key":"pntd.0014389.ref068","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"SL Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"pntd.0014389.ref069","unstructured":"World Health Organization WHO. Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. 2010. https:\/\/apps.who.int\/iris\/handle\/10665\/44412"},{"key":"pntd.0014389.ref070","volume-title":"Visceral leishmaniasis clinical development pipeline","author":"Drugs for Neglected Disease initiative (DNDi)","year":"2020"},{"issue":"2","key":"pntd.0014389.ref071","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"S Sundar","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"pntd.0014389.ref072","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"P Kaye","year":"2011","journal-title":"Nature Reviews Microbiology"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:33:14Z","timestamp":1780680794000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014389"}},"subtitle":[],"editor":[{"given":"Sanjai","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":72,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014389","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}